Effect of Febuxostat on Flow Mediated Diameter in hyperuricemia patients with chronic kidney disease 5D.
Phase of Trial: Phase II
Latest Information Update: 08 Aug 2015
At a glance
- Drugs Febuxostat (Primary)
- Indications Hyperuricaemia
- Focus Therapeutic Use
- 08 Aug 2015 Status changed from not yet recruiting to completed as per University Hospital Medical Information Network - Japan.
- 13 Aug 2014 New trial record